Citation Impact
Citing Papers
The gut microbiota and host health: a new clinical frontier
2015 Standout
Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis
2013 StandoutNobel
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
2005 Standout
Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
2013
Microbiota in health and diseases
2022 Standout
Nicotine Chemistry, Metabolism, Kinetics and Biomarkers
2009 Standout
L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy
2003
Genetic modulation of the pharmacological treatment of pain
2009
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
2015
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach
2013
Gut microbiota functions: metabolism of nutrients and other food components
2017 Standout
Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes
2002
Ulcerative Colitis
2011 Standout
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Epigenetics and the environment: emerging patterns and implications
2012 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Burden of liver diseases in the world
2018 Standout
CYP2E1 and risk of chemically mediated cancers
2010
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes
2003
Recent advances in organocatalytic methods for the synthesis of disubstituted 2- and 3-indolinones
2012 Standout
Autoimmune hepatitis
2010
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial
2010
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Macrophages: Master Regulators of Inflammation and Fibrosis
2010 Standout
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
2014 Standout
Balancing Acts
2004 Standout
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
2005
Mallory bodies revisited
2000
Sex bias in neuroscience and biomedical research
2010 Standout
Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity
2010
Paracetamol, alcohol and the liver
2000
The clinical implications of ageing for rational drug therapy
2008
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Evidence for Induction of Integron-Based Antibiotic Resistance by the SOS Response in a Clinical Setting
2012
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Ulcerative colitis
2012 Standout
Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications
2000
Crohn's disease
2016 Standout
Environmental factors influencing the development and spread of antibiotic resistance
2017 Standout
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
2017
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
2015
Pharmacokinetic-Pharmacodynamic Crisis in the Elderly
2006
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
2016
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Cutting edge issues in autoimmune hepatitis
2016
Ulcerative colitis
2016 Standout
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
2008 Standout
Acetaminophen‐induced acute liver failure
2005 Standout
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Ulcerative colitis
2020 Standout
Regulation of Hepatic Cytochromes P450 by Lipids and Cholesterol
2011
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
2017 Standout
Coffee and Health: A Review of Recent Human Research
2006 Standout
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
2001
Acetaminophen misconceptions
2004
Non-specific low back pain
2011 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine
2004
Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis
2006
An straightforward entry to new pyrazolo-fused dibenzo[1,4]diazepines
2011
Drug Therapies for Ulcerative Proctitis
2014
Management of Crohn's Disease in Adults
2009 Standout
How antibiotics kill bacteria: from targets to networks
2010 Standout
A Novel COX‐2 Inhibitor Pyrazole Derivative Proven Effective as an Anti‐Inflammatory and Analgesic Drug
2010
Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
2010
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Gender differences in drug responses
2006
Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
2015
Nuclear Receptor Ligands: Rational and Effective Therapy for Chronic Cholestatic Liver Disease?
2005
Pharmacogenomics of Human Liver Cytochrome P450 Oxidoreductase: Multifactorial Analysis and Impact on Microsomal Drug Oxidation
2009
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
2017
Robbins and Cotran Pathologic Basis of Disease
2020 Standout
New four-component reactions in water: a convergent approach to the metal-free synthesis of spiro[indoline/acenaphthylene-3,4′-pyrazolo[3,4-b]pyridine derivatives
2011
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2016
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
Liver fibrosis
2008
Role of Nuclear Receptors in the Adaptive Response to Bile Acids and Cholestasis: Pathogenetic and Therapeutic Considerations
2006
Sex Is A Major Determinant of Cyp3a4 Expression in Human Liver
2003
Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease
2015
Differential expression and function of CYP2C isoforms in human intestine and liver
2003
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
Budesonide for maintenance of remission in Crohn's disease
2014
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Growth Hormone Regulation of Sex-Dependent Liver Gene Expression
2006
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
2004
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Budesonide for induction of remission in Crohn's disease
2015
Alcoholic Liver Disease: Pathogenesis and Current Management
2017
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
2016
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
2009 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
Clinical Implications of Inflammatory Bowel Disease Genetics on Phenotype
2005
Guidelines for the Management of Inflammatory Bowel Disease in Children in the United Kingdom
2010
Pediatric Pharmacodynamics of Midazolam Oral Syrup
2000
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Works of Karin Dilger being referenced
Chronopharmacology of intravenous and oral modified release verapamil
1999
Pharmacokinetics and Pharmacodynamic Action of Budesonide in Early– and Late–Stage Primary Biliary Cirrhosis
2003
Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline
1999
Identification of Budesonide and Prednisone as Substrates of the Intestinal Drug Efflux Pump P-glycoprotein
2004
Mucosal Improvement in Patients With Moderate to Severe Postoperative Endoscopic Recurrence of Crohn’s Disease and Azathioprine Metabolite Levels
2013
Monitoring of Thiopurine Methyltransferase Activity in Postsurgical Patients With Crohn's Disease During 1 Year of Treatment With Azathioprine or Mesalazine
2007
Determination of propafenone and its phase I and phase II metabolites in plasma and urine by high-performance liquid chromatography–electrospray ionization mass spectrometry
2000
Pharmacokinetics of Mesalazine Pellets in Children With Inflammatory Bowel Disease
2004
CYP2E1 activity in patients with alcoholic liver disease
1997
Gut wall metabolism of verapamil in older people: effects of rifampicin‐mediated enzyme induction
1998
Effect of High‐Dose Metronidazole on Pharmacokinetics of Oral Budesonide and Vice Versa: A Double Drug Interaction Study
2007
Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial
2014
Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction*
1998
No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis
2005
Influence of Age and Cytochrome P450 2C9 Genotype on the Steady-State Disposition of Diclofenac and Celecoxib
2003
Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis
2010
Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health
2012
3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial
2010
Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial
2017
Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6
1999
Effects of Celecoxib and Diclofenac on Blood Pressure, Renal Function, and Vasoactive Prostanoids in Young and Elderly Subjects
2002